Skip to content

Efficacy study of oral Wasabi-sulfinyl(R) containing foods to improve cognitive function for the middle aged and elderly

Efficacy study of oral Wasabi-sulfinyl(R) containing foods to improve cognitive function for the middle aged and elderly - Efficacy study of oral Wasabi-sulfinyl(R) to improve cognitive function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027407
Enrollment
50
Registered
2018-09-23
Start date
2017-05-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Ingestion of Wasabi-sulfinyl(R) containing foods for 8 weeks Ingestion of placebo for 8 weeks

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women aged from 45 to 69 2) Subjects with self-awareness of forgetfulness 3) Subjects with inferior scores of cognitive function tests

Exclusion criteria

Exclusion criteria: 1) Subjects who are difficult to discriminate color 2) Subjects with bad eyesight, or are diagnosed with amblyopia or blindness 3) Subjects with bad hearing, or are diagnosed with hearing loss or permanent hearing loss 4) Subjects who get a score of 20 or less on the Revised HDS-R 5) Subjects with history of cranial nerve disease 6) Subjects who have depressive symptoms, or who have been diagnosed as depressive disorder 7) Subjects who are under hormone treatment or are diagnosed with menopause 8) Subjects who have some irregular schedules during the study, due to night work or something 9) Subjects who drink much alcohol 10) Subjects who smoke, or quit smoking within one year before pre-inspection 11) Subjects who have done the same cognitive function test within one year before pre-inspection 12) Subjects who are under treatment of cognitive functions, or are prescribed with medicine for them 13) Subjects who continuously take medicine, health foods, Food for Specified Health Uses or Foods with Function Claims including substance related to cognitive functions 14) Subjects who was given or donated 200 ml or 400 ml whole blood within three months before pre-inspection 15) Subjects who participated in other study within one month before pre-inspection, or are going to participate in other study during the study 16) Subjects who have a disease which needs regular medication, or have a history of the disease 17) Subjects who are judged as unsuitable for the study by investigator because of clinical test, anthropometric test and physical examination in pre-inspection 18) Subjects who are in danger of allergy to the study 19) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study 20) Subjects who are judged as unsuitable for the study because of lifestyle questionnaire 21) Subjects who are judged as unsuitable for the study by investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Rey Auditory Verbal Learning Test, Paced Auditory Serial Addition Test

Secondary

MeasureTime frame
Tapping Span , Memory of the graphic, Purdue Pegboard Test, Stroop test, Brain-derived neurotrophic factor, questionnaires

Countries

Japan

Contacts

Public ContactKotoha Isobe

TTC Co., Ltd. Clinical Research Planning Department

k.isobe@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026